Zhengye Biotechnology (ZYBT) priced its initial public offering of 1.5M shares at a public offering price of $4.00 per share.

Pholoho Biotechnology, an innovative company in the field of biotechnology, is proud to announce a significant achievement with the extraction and purification of C-Phycocyanin, a biomolecule derived ...

BofA lowered the firm’s price target on Sana Biotechnology (SANA) to $7 from $8 and keeps a Buy rating on the shares. While political and rate ...

Investing.com -- Sana Biotechnology, Inc. (NASDAQ:SANA) shares soared by nearly 400% in premarket Tuesday trading following the company's announcement of encouraging results from its study concerning ...

MAIA Biotechnology's shares rose 19% to $2.46 after the company said it entered into a clinical supply agreement with BeiGene to evaluate THIO, MAIA's telomere-targeting anticancer agent.

Upstream's breeding technologies, which protect plants from yield-threatening diseases, have already delivered strong results ...

Dr. Krishna Ell, co-founder and Executive Chairman of Bharat Biotech International, has been conferred the prestigious India Fellowship of the Indian National Science Academy (INSA) for the year 2025, ...

In a new peer reviewed analysis, scientists quantify amino acids before and after our “last universal common ancestor.” The ...

UNITY Biotechnology (UBX) strengthened the executive leadership team with the appointment of Federico Grossi, M.D., Ph.D., as chief medical ...

Sana Biotechnology released what it assessed as positive data from a study of its in-development treatment for type 1 diabetes. The company said it transplanted its treatment, UP421, an allogeneic ...

Results Demonstrate HIP-Engineered Primary Pancreatic Islet Cells Avoid Immune Detection, Function, and Persist after Intramuscular Transplantation in First Treated Patient with Type 1 Diabetes ...

National Resilience acquired the Triangle office in 2021. Since then, funding for gene therapy solutions has fallen.